Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations

Signaling Pathways in Pheochromocytomas and Paragangliomas: Prospects for Future Therapies

(2012) Svenja Nölting et al.   ENDOCRINE PATHOLOGY

New paradigms in translational science research in cancer biomarkers

(2012) Paul D. Wagner et al.   Translational Research

Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification

(2011) Graeme Eisenhofer et al.   ENDOCRINE PATHOLOGY

SDHA Immunohistochemistry Detects GermlineSDHAGene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas

(2011) Esther Korpershoek et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Malignant pheochromocytomas and paragangliomas: a diagnostic challenge

(2011) Oliver Gimm et al.   LANGENBECKS ARCHIVES OF SURGERY

Malignant pheochromocytoma: a review

(2010) Avital Harari et al.   AMERICAN JOURNAL OF SURGERY

A combined theoretical and spectroscopic study of 4,6-di-O-acetyl-2,3-dideoxy-d-erythro-hex-2-enopyranosyl sulfamide: a novel glycosyl carbonic anhydrase IX inhibitor

(2010) Martín J. Lavecchia et al.   CARBOHYDRATE RESEARCH

Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain

(2010) M. Zatovicova et al.   CURRENT PHARMACEUTICAL DESIGN

SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling

(2010) Annika Blank et al.   ENDOCRINE-RELATED CANCER

Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes

(2010) Anthony J. Gill et al.   HUMAN PATHOLOGY

Overexpression of the Mammalian Target of Rapamycin: A Novel Biomarker for Poor Survival in Resected Early Stage Non-small Cell Lung Cancer

(2010) Tony Dhillon et al.   Journal of Thoracic Oncology

HIF-1 and HIF-2 transcription factors — Similar but not identical

(2010) Agnieszka Loboda et al.   MOLECULES AND CELLS

Size of the Tumor and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS): Can They Predict Malignancy?

(2010) Amit Agarwal et al.   WORLD JOURNAL OF SURGERY

Phaeochromocytomas and sympathetic paragangliomas

(2009) B.-J. Petri et al.   BRITISH JOURNAL OF SURGERY

Novel and Evolving Therapies in the Treatment of Malignant Phaeochromocytoma: Experience with the mTOR Inhibitor Everolimus (RAD001)

(2009) M. R. Druce et al.   HORMONE AND METABOLIC RESEARCH

The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas

(2009) Judith Favier et al.   PLoS One

RECENT ADVANCES IN THE GENETICS OF PHAEOCHROMOCYTOMA AND FUNCTIONAL PARAGANGLIOMA

(2008) Anne-Paule Gimenez-Roqueplo et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Clinical manifestations of familial paraganglioma and phaeochromocytomas insuccinate dehydrogenase B(SDH-B) gene mutation carriers

(2008) Umasuthan Srirangalingam et al.   CLINICAL ENDOCRINOLOGY

Development of differential diagnosis for benign and malignant pheochromocytomas

(2008) Baohua Gao et al.   INTERNATIONAL JOURNAL OF UROLOGY

PHD2Mutation and Congenital Erythrocytosis with Paraganglioma

(2008) Charline Ladroue et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis

(2008) Vivian E. Strong et al.   SURGERY